Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT
Evaxion Biotech A/S Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Nov 14, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.34M | -10.57M | -11.46M | -15.21M | -14.69M | -22.13M | -24.47M | -24.54M | -23.62M | -23.17M | -24.67M | -24.18M | -26.23M | -24.53M | -20.43M | -19.19M | -16.01M |
Depreciation & Amortization | n/a | n/a | 115K | 315K | 315K | 315K | 771K | 571K | 571K | 571K | 344K | 344K | 344K | 344K | 29K | 29K | 29K |
Stock-Based Compensation | 357K | 357K | -21K | 79K | 79K | 79K | 42K | 242K | 242K | 242K | 379K | 679K | 1.08M | 1.08M | 1.63M | 2.63M | 2.73M |
Other Working Capital | n/a | n/a | 197K | 104K | 104K | 104K | 1.86M | 50K | 478.1K | -1.69M | -1.8M | -803.9K | -1.97M | 1.24M | 207K | 1.28M | 2.31M |
Other Non-Cash Items | 12.98M | 10.21M | 8.46M | 6.8M | 6.29M | 13.72M | 12.27M | 11.66M | 5.13M | -1.34M | 1.01M | 1.2M | 2.12M | 1.36M | -952K | 266K | 1.24M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.01M | -1.01M | -1.01M |
Change in Working Capital | n/a | n/a | 904K | 1.61M | 1.61M | 1.61M | 1.17M | -336K | 91K | -2.08M | -700K | -805K | -1.97M | 1.24M | -475K | 597K | 1.63M |
Operating Cash Flow | n/a | n/a | -2.01M | -6.4M | -6.4M | -6.4M | -10.22M | -12.4M | -17.59M | -25.77M | -24.06M | -23.79M | -26.08M | -21.93M | -22.21M | -18.68M | -13.5M |
Capital Expenditures | n/a | n/a | 1K | -64K | -64K | -64K | -4K | -28K | -111K | -292K | -529K | -772K | -1.2M | -1.36M | -1.47M | -1.14M | -670K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.95K | 21.02K | 51.9K | 36.94K | 29.95K | 30.88K | n/a | 14.96K |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -4K | 2K | 24K | 28K | 28K | 37K | -30K | -218K | -222K | -272K |
Investing Cash Flow | n/a | n/a | 1K | -64K | -64K | -64K | -9K | -32K | -109K | -268K | -501K | -744K | -1.16M | -1.33M | -1.43M | -1.11M | -658K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -107K | 7.63M | 7.49M | 7.42M | 7.49M | -289K | -165K | -117K | -100K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 5.26M | 5.35M | 5.35M | 5.35M | 642K | 415K | 194K | 194K | -1.51M | -1.38M | -1.16M | -3.76M | -2.6M | -2.73M | -2.73M |
Financial Cash Flow | n/a | n/a | 5.26M | 5.35M | 5.35M | 5.35M | 642K | 415K | 115K | 7.85M | 31.96M | 32.03M | 32.29M | 49.8M | 27.53M | 34.07M | 34.09M |
Net Cash Flow | n/a | n/a | 2.98M | -1.53M | -4.66M | -7.6M | -15.25M | -18.13M | -21.17M | -18.98M | 5.91M | 6.45M | 4.45M | 26.33M | 4.07M | 14.71M | 20.61M |
Free Cash Flow | n/a | n/a | -2.01M | -6.46M | -6.46M | -6.46M | -10.22M | -12.43M | -17.7M | -26.07M | -24.59M | -24.56M | -27.28M | -23.29M | -23.68M | -19.82M | -14.17M |